Ezuvas | Description | MIMS Thailand

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Description

Ezuvas (10 mg/10 mg): Beige, round, biconvex film coated tablets with a diameter of 10 mm approximately and "EL4" embossed on one side.
Ezuvas (20 mg/10 mg): Yellow, round, biconvex film coated tablets with a diameter of 10 mm approximately and "EL3" embossed on one side.
Each tablet contains 10 mg ezetimibe and 10 mg/20 mg rosuvastatin.
Excipients/Inactive Ingredients: Core Tablet: Lactose Monohydrate, Croscarmellose Sodium, Povidone K-29/32, Sodium Lauril sulfate, Cellulose (Microcrystalline 102), Hypromellose 2910, Colloidal Anhydrous Silica, Magnesium Stearate, Purified Water.
Coating agent for Ezuvas (10 mg/10 mg): Opadry Beige 02F270003, HPMC 2910/Hypromellose (E464), Iron oxide yellow (E172, CI77492, in compliance with commission regulation (EU) 231/2012), Titanium dioxide (E171, CI77891), Macrogol/PEG (E1521, MW4000), Talc (E553b), Purified water.
Coating agent for Ezuvas (20 mg/10 mg): Vivacoat PC-2P-308, Hypromellose (HPMC) 6 (E464), Titanium dioxide (E171, CI77891), Talc (E553b), Polyethylene glycol (PEG) (E1521, MW4000), Iron oxide yellow (E172, CI77492, in compliance with commission regulation (EU) 231/2012), Purified water.

Ezuvas Description

Manufacturer:

Sandoz

Distributor:

Zuellig Pharma

Marketer:

Sandoz